Tirzepatide nausea after dose: what the science says about GI side effects

What did @tamisolposto actually say?

The transcript provided doesn't contain coherent speech, so the factual basis here comes from the caption. The creator wrote that after taking 10mg of tirzepatide yesterday, they experienced nausea post-workout and strong appetite suppression. They framed both as expected and manageable: "tudo sob controle" (everything under control). That framing deserves scrutiny.

The caption is short but packed with implicit claims: that 10mg is a routine dose, that nausea is just a minor side effect to note and move on from, and that strong appetite suppression is a sign the drug is working well. Each of those assumptions has a more complicated reality behind it.

Does the science back this up?

Partly. Nausea is one of the most documented side effects of tirzepatide, and appetite suppression is literally the mechanism. But "under control" glosses over real risk signals that clinical data flags at this dose range.

In the SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine), nausea affected roughly 31-33% of participants at the 10mg and 15mg doses, and it was the leading reason people discontinued. That's not a trivial footnote. Nausea combined with exercise-induced physiological stress is worth paying attention to, not just hashtagging past. The GLP-1 and GIP receptor agonism that drives tirzepatide's appetite suppression also slows gastric emptying, which is a direct contributor to post-workout nausea when the stomach is already under motility stress from physical activity.

What did they get wrong (or right)?

They got the basic pharmacology right: tirzepatide does suppress appetite, and nausea is a known, expected side effect. Credit where it's due.

What's missing is context. 10mg is not a starter dose. The FDA-approved titration schedule for Zepbound and Mounjaro starts at 2.5mg weekly and increases gradually over months specifically to reduce gastrointestinal side effects. A creator casually mentioning "10mg" without any note of titration history, prescriber oversight, or how they got to that dose creates a misleading impression that this is just a normal Tuesday. For viewers who are newer to these medications, that framing can normalize dose escalation without medical supervision.

There's also no mention of hydration, which matters. Nausea on GLP-1 class drugs combined with exercise increases dehydration risk in ways that aren't obvious to someone just starting out.

What should you actually know?

Nausea on tirzepatide is not automatically a sign the drug is working. It's a side effect with a real discontinuation rate in clinical trials. In SURMOUNT-2 (Garvey et al., 2023, The Lancet), gastrointestinal adverse events were the primary driver of the roughly 6-8% dropout rate in the active treatment arms.

The "suppression of hunger" feeling that people describe as confirmation the drug is working is better understood as delayed gastric emptying combined with central appetite pathway modulation. It can feel like progress. It can also mask inadequate caloric intake, which becomes a problem for people exercising regularly.

• If you're experiencing nausea on tirzepatide, tell your prescriber before deciding it's fine.
• Nausea that follows exercise may be compounded by delayed gastric emptying from the drug itself.
• Dose increases should follow a monitored titration schedule, not personal comfort estimates.
• Strong appetite suppression does not mean you should skip eating, especially around workouts.

The bottom line

This video is a personal diary post, and there's real value in people sharing lived experience with GLP-1 medications. But the casual "everything under control" framing around a 10mg dose and workout-induced nausea is the kind of thing that looks reassuring in a caption and misses clinically important nuance. Viewers following a similar protocol without medical supervision should not take this as a template.